Metabolic Monitoring for patients on antipsychotic medications

Patients taking antipsychotic medications live with an increased risk of developing health conditions including diabetes, high blood pressure, abnormal cholesterol and triglyceride levels, and obesity. Given these risks, yearly screening and ongoing metabolic monitoring are integral to the management of antipsychotics for all individuals.    
  
Whether you’re a primary care physician, behavioral health specialist, or prescriber, you can help ensure that patients taking antipsychotic medications are receiving annual screenings by ordering HbA1c or fasting glucose tests for diabetes, along with regular cholesterol monitoring.  
  
Please be sure to use the following approved CPT codes when billing for screenings:

Close collaboration among primary care providers, behavioral health specialists, and prescribers is crucial when treating patients who are taking antipsychotic medications. We encourage providers to use CarePartners of Connecticut’s Coordination of Care Check List — or a checklist of your own — to document and share provider contacts and communicate patient diagnoses, treatments, and other information beneficial to the development of an integrated care plan.  
  
At CarePartners of Connecticut, we appreciate your commitment to closing gaps in patient care and share your dedication to ensuring that members taking antipsychotic medications receive the continuum of care they need for improved overall health.